What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.
STOCKHOLM, Sept. 25, 2023 /PRNewswire/ — SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders announced today that they have entered into a collaboration agreement with Bare Dermatology to pilot Nevisense in select…
LONDON, Sept. 25, 2023 /PRNewswire/ — Pancreatic Cancer is one of the highly prevalent types of cancer worldwide. In fact, it has been regarded as the fourth leading cause of deaths among both men and women. According to a epidemiology study conducted by the NIH, pancreatic cancer…
SHENZHEN, China, Sept. 25, 2023 /PRNewswire/ — On September 15, “Kexing Biopharm 2023 Innovation Forum on Targeted Drug Delivery” successfully kicked off. This marks the first time in recent years that the Company has organized an event specifically focused on pharmaceutical R&D…
SHANGHAI, Sept. 25, 2023 /PRNewswire/ — During HUAWEI CONNECT 2023, Huawei held the first intelligent healthcare summit themed “Build a Digital Health Community to Accelerate Intelligent Healthcare”. Huawei released the Digital Medical Technology Solution to help the healthcare industry…
BUDAPEST, Hungary, Sept. 25, 2023 /PRNewswire/ — Omixon Biocomputing Ltd. announced today the launch of NanoTYPE MONO™ and MONO all™ – RUO, a single locus human leukocyte antigen (HLA) amplification kit compatible with Oxford Nanopore’s MinION ™ platform NanoTYPE MONO is designed to…
“We are extremely excited about sharing the unique experience of the Crunch brand with the residents surrounding our newest location in Sunrise,” said CR Fitness Holdings CEO Tony Scrimale. “We can’t wait to show you how we combine top-notch equipment, extraordinary classes, and personal training at an unbeatable value.”
Fusing fitness with entertainment, Crunch Sunrise boasts top-quality strength training equipment, an extensive selection of premier cardio equipment, Hot Yoga, a Group Fitness Studio, HIITZone™, a Cycling Studio, a Training Hub, Dry Saunas, HydroMassage®, tanning facilities, and spacious locker rooms, among other amenities.
CR Fitness Holdings is operated by industry veterans Vince Julian, Geoff Dyer, Jeff Dotson, and Tony Scrimale with an impressive combined experience of over 150 years in the fitness sector. Presently, the CR Fitness team operates 53 Crunch Fitness locations spanning Florida, Georgia, North Carolina, and Texas. The impending arrival of Crunch Sunrise as the 54th location not only adds to our expanding footprint but also contributes to the creation of more job opportunities in South Florida.
To kickstart the festivities and provide our community with a preview of what’s to come, Crunch Sunrise will host a “Sneak Peek Sip Sip” event on Thursday, September 28 from 6 p.m. to 9 p.m. Crunch Fitness invites all to join in the festivities and begin your journey to a healthier, happier lifestyle.
Media Contact
Tricia Mason, Crunch Fitness, 813 601 7471, [email protected], crunch.com
SOURCE Crunch Fitness
NEW YORK, Sept. 24, 2023 /PRNewswire/ — The thyroid gland disorder treatment market is expected to grow by USD 868.87 million from 2022 to 2027. In addition, the growth momentum of the market will progress at a CAGR of 5.33% during the forecast period, according to Technavio. The rise in…
NEW YORK, Sept. 24, 2023 /PRNewswire/ — The immunohematology market is expected to grow by USD 1.28 billion from 2022 to 2027. However, the growth momentum of the market will progress at a CAGR of 9.06% during the forecast period. The market is segmented by product (analyzers and systems…
STOCKHOLM, Sept. 25, 2023 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that “LEQEMBI® Intravenous Infusion” (200 mg, 500mg, lecanemab) has been approved in Japan as a treatment for slowing progression of mild cognitive impairment (MCI) and…
STOCKHOLM, Sept. 25, 2023 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that “LEQEMBI® Intravenous Infusion” (200 mg, 500mg, lecanemab) has been approved in Japan as a treatment for slowing progression of mild cognitive impairment (MCI) and…
